HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

oligodendrocyte-myelin glycoprotein

amino acid sequence given in first source; glycophospholipid-linked membrane protein of oligodendrocytes & central nervous system myelin; RefSeq NM_206814 (human), NM_022668 (Mog, rat), NM_010814 (mouse)
Also Known As:
MOG glycoprotein; MOG protein, human; Mobp protein, rat; Mog protein, mouse; Mog protein, rat; myelin oligodendrocyte glycoprotein; myelin oligodendrocyte glycoprotein, human; myelin oligodendrocyte glycoprotein, mouse; myelin oligodendrocyte glycoprotein, rat; myelin-associated oligodendrocyte basic protein; myelin-associated oligodendrocytic basic protein, rat; myelin-oligodendrocyte associated protein; myelin-oligodendrocyte glycoprotein
Networked: 714 relevant articles (23 outcomes, 77 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Weissert, Robert: 21 articles (01/2016 - 07/2002)
2. Olsson, Tomas: 21 articles (01/2015 - 07/2002)
3. Lassmann, Hans: 19 articles (12/2015 - 06/2002)
4. Linker, Ralf A: 17 articles (02/2015 - 06/2002)
5. Gold, Ralf: 15 articles (02/2015 - 06/2002)
6. Linington, Christopher: 15 articles (01/2015 - 07/2002)
7. Bauer, Jan: 15 articles (12/2013 - 07/2002)
8. Reindl, Markus: 14 articles (12/2015 - 10/2002)
9. Bähr, Mathias: 13 articles (01/2015 - 08/2003)
10. Storch, Maria K: 13 articles (01/2011 - 07/2002)

Related Diseases

1. Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
2. Inflammation
3. Multiple Sclerosis
4. Demyelinating Diseases (Demyelinating Disease)
5. Autoimmune Diseases (Autoimmune Disease)

Related Drugs and Biologics

1. Antigens
2. sildenafil (Viagra)
3. Phenytoin (Dilantin)
4. Sodium Channels (Sodium Channel)
5. ginsenoside Rd
6. Cytokines
7. Methylprednisolone
8. Type 5 Cyclic Nucleotide Phosphodiesterases
9. Purinergic P1 Receptors (Adenosine Receptor)
10. Thalidomide (Thalomid)

Related Therapies and Procedures

1. Transplantation (Transplant Recipients)
2. Oral Administration
3. Intravenous Injections
4. Injections
5. Subcutaneous Injections